Straits Times Index
3,227.10 -35.97 (-1.10%) S&P 500
3,693.23 -64.76 (-1.72%) Dow
29,590.41 -486.29 (-1.62%) Nasdaq
10,867.93 -198.87 (-1.80%) BTC-USD
18,825.53 -91.35 (-0.48%) CMC Crypto 200
434.61 -9.92 (-2.23%)
Teladoc Health, Inc. (TDOC)
After hours:
| Previous close | 27.96 |
| Open | 27.67 |
| Bid | 26.99 x 800 |
| Ask | 27.49 x 800 |
| Day's range | 26.23 - 28.03 |
| 52-week range | 26.23 - 156.82 |
| Volume | |
| Avg. volume | 5,055,703 |
| Market cap | 4.36B |
| Beta (5Y monthly) | 0.86 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -43.42 |
| Earnings date | 25 Oct 2022 - 31 Oct 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 36.52 |
- Motley Fool
2 Potentially Explosive Stocks to Buy in September
These two stocks have such solid growth potential that you might want to buy them before September ends.
- Motley Fool
2 Stocks to Buy Near Their 52-Week Lows
Thankfully, both companies have plenty of opportunities that could pay off for patient investors. Let's consider why Zoetis and Teladoc are worth buying while they are still hovering near their 52-week lows. Teladoc stock imploded this year as net losses piled up, mainly due to non-cash goodwill impairment charges related to its acquisition of Livongo Health.
- Motley Fool
Better Growth Stock: Moderna vs. Teladoc
It may be a bit early to establish Moderna's (NASDAQ: MRNA) and Teladoc Health's (NYSE: TDOC) lasting growth stock status by looking at the past couple of years. Moderna launched the coronavirus vaccine as its first product in 2020 -- and vaccinated a good share of the population. Teladoc saw revenue and virtual medical visits soar in the triple digits as people opted to stick close to home.
